ITGAX and rheumatoid arthritis: We and others have shown that the CD21−/low fraction of B cells and its subsets are expanded in patients with established (est) RA [8, 14–18], and in one of these studies, a positive correlation between disease activity and a CD21−/low subset that was CD27−IgD− (double negative, DN) CD11c+ was reported [18].